Advertisement

Progression of glomerular diseases: risk factors and clinical overview

  • George E. Schreiner
Part of the Developments in Nephrology book series (DINE, volume 34)

Abstract

The great renal physiologist, Homer Smith, once wrote, “We are what we are because we have the kind of kidneys we have”. Thus, the important questions in nephrology are those which deal with a chemical milieu consistent with a high quality of life. When that milieu is optimal or tolerable, the nuances of social decisions become highly relevant. However, when that chemical milieu is suboptimal or intolerable due to declining kidney function, the actions of society become almost irrelevant to the patient except those actions directed toward making metabolic improvement possible.

Keywords

Kidney Function Renal Biopsy Progressive Decline Chemotactic Factor Membranous Glomerulonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davies DF, Shock NW. Changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29:496.PubMedCrossRefGoogle Scholar
  2. 2.
    Wesson L. Physiology of the Human Kidney, Grune and Stratton, 1969; 98.Google Scholar
  3. 3.
    Rowe JW, Tobin JD, Shock NW. The effect of age on creatinine clearance in man: A cross-sectional and longitudinal study. J Gerentol 1976; 31:155.CrossRefGoogle Scholar
  4. 4.
    Lindemann RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriat Soc 1985; 33:278–285.Google Scholar
  5. 5.
    Klahr S, Schreiner G, Ishikawa I. The progression of renal disease. N Eng J Med 1988; 1657–1666.Google Scholar
  6. 6.
    Argy WP, Chester AC, Siemson AS, Rakowski TA, Schreiner GE. Hypertension in two hemodialysis cohorts. Trans Am Soc Artif Intern Organ 1982; 28:330.Google Scholar
  7. 7.
    Rostand SG, Brown G, Kirk KA, Rutsky EA, Dustan HP. Renal insufficiency in trated essential hypertension. N Eng J Med 1989; 320:684.CrossRefGoogle Scholar
  8. 8.
    Schreiner GE. The nephrotic syndrome. In: Strauss MB, Welt LG, editors. Diseases of the Kidney, Little, Brown, 1st Edition 1963; 334 ff.Google Scholar
  9. 9.
    Berman LG, Schreiner GE. Clinical and histological spectrum of the nephrotic syndrome. Am J Med 1958; 24:249.PubMedCrossRefGoogle Scholar
  10. 10.
    Hess EV, Ashworth CI, Ziff M. Transfer of auto immune nephritis in rats by means of lymph NoOE cells. Clin Res 1961; 9:48.Google Scholar
  11. 11.
    Velosa JA, Holey KE, Torres VE, Offord KP. Analysis of other factors possibly associated with duration to end-stage renal failure. Mayo Clin Proc 1983; 58:573.Google Scholar
  12. 12.
    Pabico RC, Cala CR, McKenna BA, Freeman RB. Massive proteinuria and its effects on renal tubular functions. Eur Dial Transplant Ass 1977; 14:495.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1993

Authors and Affiliations

  • George E. Schreiner

There are no affiliations available

Personalised recommendations